Clinical trial
A Phase 2 Study to Evaluate the Efficacy and Safety of Temozolomide in Advanced Gastrointestinal Stromal Tumor Patients With SDH Deficiency
NCT05661643 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Study to Evaluate the Efficacy and Safety of Temozolomide in Advanced Gastrointestinal Stromal Tumor Patients With SDH Deficiency
- Lead sponsor
- Asan Medical Center
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- June 28, 2023
- Completion date
- December 31, 2027
- Enrollment
- 29 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.